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Summary: Attitudes of general practitioners (GPs) towards A/H1N1 pandemic vaccination 
are unknown. We conducted a cross-sectional survey with computer-assisted telephone 
interviewing in the French Regional Panel of General Practices from June 16 to September 
22, 2009. Of 1,434 respondents representative of GPs in four French regions, 885 (61.7%) 
were willing to accept A/H1N1 pandemic vaccination for themselves. The personal history of 
seasonal flu vaccination was the strongest independent predictive factor of willingness to 
accept A/H1N1 pandemic vaccination (P<.0001). GPs receiving seasonal vaccines every year 
were more likely to accept A/H1N1 pandemic vaccination than those who were never 
vaccinated in the prior three years (adjusted OR=4.38; 95% CI, 2.44 to 4.67). Willingness to 
accept pandemic vaccination was also significantly associated with being on call for 
emergencies; positive attitudes towards other protective measures against A/H1N1 influenza 
virus in the practice; and a higher readiness to provide additional consultations in response to 
the pandemic. In conclusion, GPs showed a high acceptability of A/H1N1 pandemic 
vaccination. GPs’ involvement in the mass vaccination campaign, which has been neglected 
by French public health authorities, may have increased uptake rates in the general public. 
 
Keywords: pandemic vaccination; influenza; healthcare workers; general practice 
 
Running headline: Acceptability of pandemic vaccination among GPs
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Introduction 
On June 11, 2009, the World Health Organization (WHO) declared a pandemic due to the 
novel A/H1N1 2009 influenza virus [1]. Forty countries embarked thereafter in national 
A/H1N1 pandemic vaccination campaigns to mitigate the transmission of the virus [2]. In 
France, with a population of around 63.5 million, the government bought 94 million doses of 
A/H1N1 pandemic vaccines [3]. On October 20, the distribution of available vaccine supply 
started in hospitals for 1.2 million healthcare workers including doctors and nurses of primary 
care settings [4, 5]. On November 12, the access to vaccines was extended in mass 
vaccination centres to 2.8 million at-risk people aged 6 months to 64 years, 1.7 million 
household contacts and caregivers for children younger than 6 months of age, and 880,000 
additional healthcare workers in primary care settings [4, 5]. Contrary to the seasonal flu 
vaccine that is usually prescribed and administered by general practitioners (GPs) in 
ambulatory medicine, GPs have not been allowed to participate in the pandemic vaccination 
campaign for logistical reasons. The French situation is in sharp contrast with neighbouring 
countries where GPs administer pandemic vaccines in accordance with their pivotal role in 
seasonal influenza vaccination campaigns, like in Belgium, or even receive financial 
incentives to vaccinate people at risk, like in the UK [6]. As of November 22
nd
, pandemic 
vaccine uptake rates remained below 10% in both hospitals and mass vaccination centres [7], 
although the A/H1N1 pandemic outbreak had already been responsible for 357 
hospitalizations of severe diseases and 68 deaths [8]. 
The initial low uptake rates observed in France may largely be attributable to the ongoing 
public controversy about the safety of new pandemic vaccines and the rationale for mass 
vaccination of the whole population [9-14]. As a consequence, the general public including 
people identified as being at risk may increasingly look for advice from their GPs. Previous 
studies have shown that GPs’ personal behaviours and attitudes towards seasonal influenza 
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vaccination are associated strongly with their patients’ immunization behaviour [15-18]. 
Accordingly, French GPs’ counselling to their clientele, and to the general public as a whole, 
may have a significant influence on the public acceptability of the mass vaccination 
campaign. A better understanding of GPs attitudes and behaviours toward A/H1N1 pandemic 
vaccination is therefore of utmost importance. 
We conducted a telephone survey among a representative sample of GPs in four French 
regions between June 16 and September 22, 2009, to evaluate their willingness to accept 
A/H1N1 pandemic vaccination for themselves. We investigated how a variety of factors, 
including individual and occupational characteristics as well as personal history of seasonal 
influenza vaccination receipt, may affect GPs’ willingness to accept A/H1N1 pandemic 
vaccination for themselves. We also investigated the relationships between GPs’ attitudes 
towards pandemic vaccination and their attitudes towards other protective measures against 
A/H1N1 2009 influenza virus in the practice and their readiness to provide additional 
consultations in response to the pandemic.
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Methods 
Participants 
The present study was part of the fifth cross-sectional survey conducted in the frame of the 
French Regional Panel of General Practices. This Panel survey was initiated in March 2007 
with the objective to study medical practice of French GPs who account for 56% of 
ambulatory physicians [19, 20]. Four regions were selected as a function of their diverse 
medical density: Lower Normandy, Burgundy, Brittany and Provence-Alpes-Côte d’Azur 
(called South-Eastern region in the following) with ratios of 96, 101, 107, and 136 GPs per 
100,000 inhabitants, respectively [21]. GPs were selected for stratified random sampling from 
the ADELI (“Automatisation DEs LIstes”) database of the Ministry of Health which contains 
exhaustive information on French physicians. The ADELI database was stratified for region, 
location of the general practice (in urban, suburban or rural areas), gender, and age (<45; 45 to 
52; >52). GPs practicing exclusively in hospitals or long term care facilities, GPs practicing 
exclusively alternative medicines (such as homeopathy or acupuncture), GPs who were not 
practicing at time of the survey due to sick leave or retirement, and GPs planning to move out 
of their present region in the next six months were excluded. GPs received a compensation 
equivalent to 2 consultation fees for their participation to each cross-sectional survey. 
Participant GPs, who dropped out in a following cross-sectional survey, were randomly 
replaced according to their stratum. 
Of the 2,498 eligible GPs invited to participate to the French Regional Panel of General 
Practices in March 2007, 1,451 (58.1%) gave their agreement to participate. The 1,047 GPs 
who refused to participate did not differ from participants according to practice location and 
gender, but they were older (P=.02). Lack of time was their main reason for refusal. Results 
presented in this paper are based on the 1,434 panel GPs who participated to the fifth cross-
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sectional survey conducted between June 16 and September 22, 2009 (response rate of 
1,434/1,451; 98.8%). 
 
Procedure and questionnaire 
The survey was conducted among GPs by professional investigators with computer-assisted 
telephone interviewing. The questionnaire was pilot-tested for clarity, length and face validity 
among 20 GPs.  
Respondents were asked whether or not they would accept the A/H1N1 pandemic vaccination 
for themselves as soon as it became available. In addition, they were asked to assess the 
importance of other protective measures against A/H1N1 2009 influenza virus in the practice 
on a 10-point scale from 1 “not important at all” to 10 “of utmost importance”: 1) to wear a 
facial mask during each clinical encounter with patients; 2) to provide facial masks to all 
patients and having them wear it in the practice; 3) to recommend patients with influenza-like 
illness to stay at home and to visit them at home for medical care. A total score of importance 
of A/H1N1 protective measures was also computed by aggregating the answers to these three 
items [min=3 to max=30]. 
Moreover, respondents were asked what was the maximum number of additional consultations 
they would be ready to provide per day at the peak of the influenza-pandemic to care for 
patients with flu or to vaccinate the population. Respondents were asked how many times they 
had been vaccinated against seasonal influenza in the prior three years (each year, twice, once, 
never); whether they had read the “national plan for influenza-pandemic preparedness and 
response” (yes/no); and whether the primary objective of pandemic vaccination should be “to 
protect individuals at higher risk for influenza complications” or “to mitigate the transmission 
of influenza virus in the whole population”. 
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The questionnaire also collected data on individual and occupational characteristics of 
respondents: gender and age; solo or group practice; being on call for emergencies; working 
part-time in long term care facilities or in hospitals in addition to their ambulatory practice; 
practicing some alternative medicine such as homeopathy; participating in Continuing 
Medical Education during the previous year (CME); payment scheme for consultation (Social 
Security fixed fees or free pricing). Observational data on GP’s activity in 2007 and 2008 was 
obtained, in parallel to the survey, from the Social Security exhaustive reimbursement 
database that includes for each GP the total number of consultations and home visits per year, 
and the age distribution of the GP’s clientele according to four age categories (less than 16; 16 
to 59; 60 to 70; more than 70). 
The survey was approved by the National Data Protection Authority (Commission Nationale 
Informatique et Libertés/ CNIL) which is in charge of ethical issues and protection of 
individual data collection in France. 
 
Statistical analysis 
The main outcome variable was GP’s willingness to accept A/H1N1 pandemic vaccination for 
themselves (yes versus no or don’t know). Univariate associations between respondent’s 
willingness to accept A/H1N1 pandemic vaccination and other variables were tested using 
logistic regression. Explanatory variables, that were related to willingness to accept A/H1N1 
pandemic vaccination at the p≤.15 level, were subsequently introduced in a backward 
multivariate logistic model (p exit>.05) to identify independent predictive factors for such 
willingness. Region, location of general practice, gender, and age were forced in the final 
regression model since these variables had been used to stratify the sample. Adjusted odds 
ratios and 95% confidence intervals were presented for the main findings. Data were analysed 
using SAS 9.1.3 (SAS Institute, Cary NC).
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Results 
Individual and occupational characteristics of the 1,434 GPs who participated in the survey, as 
well as characteristics of their practice, are detailed in Table 1. A total of 885 respondents 
(61.7%) declared their willingness to accept A/H1N1 pandemic vaccination for themselves as 
soon as it became available, while an even higher proportion (70.6%) had systematically been 
vaccinated for seasonal influenza in the prior three years (Table 2). On average, GPs were 
ready to increase their workload in response to the pandemic by undertaking 11.6 (sd = 6.5) 
consultations per day in addition to their usual practice activity. A large majority of 
respondents agreed that the main objective of pandemic vaccination was the public health 
goal to mitigate the transmission of the influenza virus in the whole population and had some 
knowledge of the national preparedness plan against an influenza-pandemic. Respectively, 
36.8%, 39.5%, and 38.9% declared that it was “of utmost importance” (score = 10) that the 
GP wears a facial protective mask with each patient; orders patient to wear facial masks in the 
practice; and recommends influenza-ill patients to stay at home. Table 2 also presents the 
scores of importance that GPs associated with these three measures of protection against 
A/H1N1 2009 influenza virus in the practice. 
Univariate analyses showed that willingness to accept A/H1N1 pandemic vaccination did not 
vary significantly according to the four individual characteristics used for stratification in the 
survey: region, location of general practice, gender, and age. Several occupational 
characteristics of GPs and their practice (working part-time in hospitals in parallel to their 
ambulatory practice; participating in CME; and type of payment scheme) were not associated 
with acceptability of A/H1N1 vaccination. Age distribution of GP’s clientele was also not 
associated with their personal intention towards vaccination. 
By contrast, as shown in Table 3, some GPs’ characteristics were found to be significantly 
related to their willingness to accept A/H1N1 pandemic vaccination even after adjustment 
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through multivariate logistic analysis. GPs more willing to get vaccinated were those: 
working in group practices; being on call for emergencies; working part-time in long term 
care facilities (usually for the elderly) in parallel to their ambulatory practice; and having the 
highest workload in practice (more than 4000 consultations per year). Quite logically, GPs 
who were more ready to increase their workload in response to the pandemic, who adhered 
the most to implementing other protective measures in their practice, and who believed that 
mitigation of transmission of the influenza virus in the whole population was the primary 
objective of pandemic vaccination were also more willing to accept A/H1N1 pandemic 
vaccination for themselves. The multivariate logistic analysis presented in Table 3 highlights 
that history of seasonal flu vaccination in the prior three years was the strongest predictive 
factor of willingness to accept A/H1N1 pandemic vaccination. This willingness increased 
significantly with the number of seasonal flu vaccines received in the prior three years 
(Cochran-Armitage test for trend: P<.0001). 
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Discussion 
This survey was conducted during the summer of 2009 among a sample of 1,434 GPs 
representative of all GPs in ambulatory medicine in four French regions and revealed quite a 
high acceptability of A/H1N1 pandemic vaccination in this professional group. A large 
majority of GPs (61.7%) were willing to accept such vaccination for themselves as soon as it 
became available. To our knowledge, no other study had explored the willingness to accept 
A/H1N1 pandemic vaccination in general ambulatory practice since WHO declared the 
A/H1N1 influenza-pandemic. Only one study was conducted among 389 healthcare workers, 
but in the quite different context of Hong Kong public hospitals, and found that less than half 
(47.9%) were willing to accept A/H1N1 pandemic vaccination in May 2009 [22]. 
The positive attitude of French GPs towards A/H1N1 pandemic vaccination is coherent with 
previous observed behaviours of GPs towards seasonal influenza vaccination. Seasonal 
influenza vaccination has been recommended for more than 25 years to all healthcare 
workers, but average uptake rates have remained quite low, usually close to 20% in most 
countries [18, 23]. However, the few surveys carried out among GPs suggest a higher 
acceptability of seasonal vaccination in this professional group. Two cross-sectional studies 
conducted among GPs in France and the Belgian French community found uptake rates at 
about 66% in the previous influenza season [24, 25], while other studies provided estimates 
ranging from 36% to 82% [16, 26-28]. In our survey, 70.6% of GPs had received the seasonal 
influenza vaccine every year in the prior three years and their personal history of seasonal 
vaccination receipt was strongly related to their acceptability of the A/H1N1 pandemic 
vaccination with a significant trend towards an exposure-effect relationship. Previous studies 
conducted among healthcare workers showed a similar relationship between the receipt of 
influenza vaccine in the previous season and willingness to accept: 1) seasonal influenza 
vaccine in general practice [27, 28], hospitals [29], and long term care facilities [30, 31]; 2) 
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pre-pandemic A/H5N1 influenza vaccines in hospitals [22, 32]; and 3) A/H1N1 influenza 
pandemic vaccines in hospitals [22]. In addition, previous receipt of seasonal flu vaccines was 
associated with willingness to accept unapproved influenza-pandemic vaccination in June 
2009 among the general public in the US [14]. 
The quite high personal uptake rate of seasonal influenza vaccination among French GPs is 
assumingly related to their pivotal role in the management of seasonal influenza. French GPs 
care for patients with influenza-like illnesses and are thus highly exposed to the virus [33], 
and they are mostly in charge of the vaccination of the elderly and of patients at higher risk 
for influenza complications [18]. Similarly, the higher willingness observed in GPs being on 
call for emergencies, having already higher workloads, and working in group practices 
suggests that these primary care physicians may have a higher perception of the risk of being 
exposed to A/H1N1 2009 influenza virus and/or a higher consciousness of their public health 
responsibilities in case of an influenza-pandemic. Also, the higher willingness observed in 
GPs having a part-time activity in long term care facilities suggests that GPs have more 
experience vaccinating the elderly against seasonal influenza, and may therefore be more 
willing to vaccinate in general because of an increased comfort level. 
French GPs’ experience with management of seasonal influenza seems to translate into a 
positive attitude towards A/H1N1 pandemic vaccination and a high willingness to contribute 
to the public health mobilization against the A/H1N1 influenza-pandemic. GPs who accepted 
pandemic vaccination for themselves were also more likely to be informed of the national 
preparedness plan against an influenza-pandemic, to support mass vaccination to mitigate the 
transmission of the virus, and to take an active role against the influenza-pandemic by 
recommending protective behaviours to their patients and by increasing their workload in 
practices. Accordingly, the decision of French public authorities not to allow GPs to actively 
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participate in the mass vaccination campaign may have disregarded a significant public health 
potential to increase vaccination uptakes in the general public. 
While the clinical severity of A/H1N1 2009 influenza-pandemic appeared lower in the 
Southern Hemisphere during the summer [34, 35], the public media attention shifted towards 
the safety of A/H1N1 pandemic vaccines with regard to the risk of Guillain-Barré syndrome 
as observed during the 1976 swine flu vaccination campaign in the United States [9], the 
unknown safety of adjuvanted vaccines, the unclear number of vaccine injections needed for 
efficacy, the accelerated authorization procedure to market pandemic vaccines, and actual 
motivations of pharmaceutical firms. Several opinion leaders and politicians reinforced this 
negative trend of attitudes towards vaccination by criticizing French public authorities 
regarding a communication strategy “overstressing potential health risks of the influenza-
pandemic”. In a qualitative study among healthcare workers and the general public, Henrich 
and Holmes found that individuals were hesitant to accept pandemic vaccines and that 
“concerns about using new vaccines during a pandemic differ from concerns about using 
established products in non-crisis situations” [13]. In such context of negative messages about 
the pandemic vaccination, the success of the mass vaccination campaign may partly rely on 
GPs’ capacity to advise the general public in favour of pandemic vaccination since GPs’ 
behaviours and attitudes towards seasonal influenza vaccination have already been shown to 
associate with patient immunization behaviour [15-18]. 
Some limitations of our study should be acknowledged. First, our sample only covered four 
French regions and not the whole country. However, it was carried out in the frame of the 
French Regional Panel of General Practices providing a global picture of French ambulatory 
medicine from regions of contrasted density of GPs; socio-professional characteristics of GPs 
were similar to those observed at the national level [21]. In addition, our sample of GPs was 
stratified for four individual characteristics (i.e., region, location of general practices, gender, 
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and age), and none was found to be associated with willingness to accept A/H1N1 pandemic 
vaccination. Accordingly, the study results may apply more broadly to French GPs. Second, 
this survey was carried out before the pandemic vaccine was available and consequently 
before the vaccination started among health care workers included as the first priority group 
for vaccination. Thus, acceptability of A/H1N1 vaccine was measured through attitudes and 
declared intentions rather than observed actual behaviours. However, the strong relationship 
between previous behaviours towards seasonal influenza vaccination and acceptability of 
A/H1N1 pandemic vaccine suggests that it may adequately reflect effective uptake
 
rates in 
GPs. Third, while the personal history of seasonal influenza vaccination receipt was self-
reported, the verification of medical records could have dismissed a possible social 
desirability bias. 
One month after the mass A/H1N1 pandemic vaccination campaign started in France on 
October 20, uptake rates remained below 10% among hospital healthcare workers. Since then, 
in parallel to an increase in the number of hospitalizations due to severe complications of 
A/H1N1 influenza, uptake rates have increased among both health care professionals and the 
general public. As of January 4
th
, 2010, about 5 million people (7.9% coverage) have been 
vaccinated in France [36]. Our survey however suggests that French public authorities may 
have made a mistake by not involving directly their GPs in the mass vaccination campaign 
and should urgently consider revising this policy. 
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Gender
Male 1,063 (74.1)
Female 371 (25.9)
Age, mean (SD), year 49.8 (7.6)
Region
South-Eastern France 585 (40.8)
Brittany 388 (27.0)
Burgundy 265 (18.5)
Lower Normandy 196 (13.7)
Location of general practice
Urban 903 (63.0)
Rural 307 (21.4)
Suburban 224 (15.6)
Practice type
Solo 766 (46.6)
Group 668 (53.4)
On call for emergencies
No 779 (54.3)
Yes 655 (45.7)
Part-time activity in long term care facilities
No 925 (64.5)
Yes 509 (35.5)
Part-time activity in hospitals
No 1,224 (85.4)
Yes 210 (14.6)
Practicing some alternative medicine (homeopathy)
No 1,357 (94.6)
Yes 77 (5.4)
Participation to Continuing Medical Education in the past year
No 247 (16.5)
Yes 1,197 (83.5)
Payment scheme (fee-for-service)
Social Security Fixed price 1,326 (92.5)
Free pricing 108 (7.5)
4,864 (2103)
Patients < 16 years old in 2007-2008, mean (SD) 19.9 (6.7)
Patients 60-69 years old in 2007-2008, mean (SD) 9.7 (3.1)
Patients > 70 years old in 2007-2008, mean (SD) 15.2 (7.4)
Table 1. Individual and occupational characteristics of French GPs participating in the 
survey about A/H1N1 influenza pandemic (N=1,434, June 16 to September 22, 2009).*
* Values are numbers (percentage) of respondents, except where stated otherwise.
Consultations and home visits in 2007-2008, mean (SD), total per year
Age distribution of GP's clientele in percentage
Characteristics
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Yes 885 (61.7)
No 474 (33.1)
Don't know 75 (5.2)
Every year 1,013 (70.6)
Twice 110 (7.7)
Once 90 (6.3)
Never 221(15.4)
Yes 1,238 (86.3)
No 196 (13.7)
To limit the transmission of the virus in the whole population 1,071 (74.7)
To protect individuals at higher risk for influenza complications 363 (25.3)
Wearing a facial mask with each patient 7.0 (3.2)
Ordering patients to wear a facial mask in the practice 7.1 (3.2)
Recommending patients with flu to stay at home 7.2 (3.1)
21.3 (6.6)
11.6 (6.5)
* Values are numbers (percentage) of respondents, except where stated otherwise.
†Score ranging from 1 (not important at all) to 10 (of utmost importance)
Score of importance of protective measures against A/H1N1 pandemic, mean (SD), (1-10) score†
Has read the national preparedness plan against an influenza-pandemic
Primary objective of influenza-pandemic vaccination
Additional workload to respond to A/H1N1 influenza pandemic, mean (SD), max number of consultations 
per day
Total score of importance of 3 protective measures against A/H1N1 pandemic, mean (SD), (3-30) score
Characteristics
Table 2. Beliefs, attitudes, and opinions of French GPs toward the A/H1N1 influenza-pandemic (N=1,434).*
Willingness of GPs to accept A/H1N1 pandemic vaccination for themselves
Had been vaccinated against seasonal influenza in the prior three years
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No (%) willing to 
accept pandemic 
vaccination
Unadjusted 
odds ratio p value
Adjusted odds 
ratio (95% CI)‡ p value
Solo 428 (55.9) 1 [reference] 1 [reference]
Group 457 (68.4) 1.71 <.0001 1.39 (1.10 to 1.77) .006
No 421 (54.0) 1 [reference] 1 [reference]
Yes 464 (70.8) 2.07 <.0001 1.94 (1.50 to 2.51) <.0001
No 531 (57.4) 1 [reference] 1 [reference]
Yes 354 (69.6) 1.70 <.0001 1.44 (1.11 to 1.86) .006
No 852 (62.8) 1 [reference] --
Yes 33 (42.9) 0.45 .001
No 197 (57.3) 1 [reference] --
Yes 688 (63.1) 1.28 .052
<= 4,000  per year 264 (54.0) 1 [reference] 1 [reference]
> 4,000 total  per year 621 (65.7) 1.63 <.001 1.38 (1.06 to 1.78) .015
Never 84 (38.0) 1 [reference] (<.0001) 1 [reference] (<.0001)
Once 43 (47.8) 1.49 .113 1.54 (0.91 to 2.62) .107
Twice 68 (61.8) 2.64 <.0001 2.61 (1.58 to 4.30) <.001
Every year 690 (68.1) 3.48 <.0001 3.38 (2.44 to 4.67) <.0001
No 105 (53.6) 1 [reference] --
Yes 780 (63.0) 1.48 .012
To protect individuals at higher risk for influenza complications 195 (53.7) 1 [reference] 1 [reference]
To limit the transmission of the virus in the whole population 690 (64.4) 1.56 .001 1.44 (1.11 to 1.87) .007
<= 20 295 (51.0) 1 [reference] 1 [reference]
> 20 590 (69.0) 2.14 <.0001 2.34 (1.85 to 2.96) <.0001
<= 10 consultations per day 572 (59.1) 1 [reference] 1 [reference]
> 10 consultations per day 313 (67.2) 1.41 .002 1.39 (1.10 to 1.77) .007
‡ Adjusted odds ratio were also controlled for region, location of general practice, gender, and age used to stratify the sample; these variables were not significant in 
univariate analyses (p=.377; p=.835; p=.266; and p=.281, respectively). Hosmer-Lemeshow test: P=.78, suggests that the goodness of fit was adequate for the final 
† Only variables associated with willingness to accept A/H1N1 pandemic vaccination at the p≤.15 level in univariate analysis are shown
Had been vaccinated against seasonal influenza in the prior three years
Part-time activity in long term care facilities
Practicing some alternative medicine (homeopathy)
Participation to Continuing Medical Education in the past year
Table 3. Factors associated with willingness of GPs to accept A/H1N1 pandemic vaccination for themselves: univariate and multivariate logistic models (N=1,434 
GPs)
Variables and variable levels†
Total number of consultations and home visits in 2007-2008*
* Continuous variables were also significantly associated to willingness to accept A/H1N1 pandemic vaccination in the multivariate logistic model and were dichotomized at 
the median value for presentation of the final multivariate model
Total score of importance of protective measures against A/H1N1 influenza pandemic*
Readiness to provide additional consultations in response to A/H1N1 influenza pandemic*
Primary objective of influenza-pandemic vaccination
Has read the national preparedness plan against an influenza-pandemic
Practice type
On call for emergencies
 
